|
|
Article: Inspire Pharmaceuticals, Inc. Reports Positive Preclinical Results for Novel Therapeutic Approach for Vaginal Dryness.
- Article from:
- PR Newswire
- Article date:
- October 30, 2000
CopyrightCOPYRIGHT 2000 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- Data Presented at Scientific Meeting in Boston, Massachusetts -
DURHAM, N.C., Oct. 30 /PRNewswire/ --
Inspire Pharmaceuticals, Inc. (Nasdaq: ISPH) announced positive results from studies of gel formulations of two P2Y2 receptor agonists in scientific sessions at the New Perspectives in the Management of Female Sexual Dysfunction Meeting in Boston, Massachusetts, October 28, 2000. Dr. Jennifer Berman, Co-Director for the Center for Pelvic Medicine and Female Sexual Health at the UCLA Medical Center, reported data from an in vivo study of the effects of gel formulations of P2Y2 receptor agonists on vaginal mucosal health in rabbits. According to the ...